2.4(top 20%)
impact factor
7.2K(top 5%)
papers
149.6K(top 5%)
citations
120(top 5%)
h-index
2.5(top 20%)
impact factor
9.8K
all documents
157.1K
doc citations
169(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology2002910
2Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adultsPediatric Pulmonology2020791
3Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patientsPediatric Pulmonology2009685
4Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Young, Mechanically Ventilated ChildrenPediatric Pulmonology2006605
5Pulmonary function between 6 and 18 years of agePediatric Pulmonology1993593
6Respiration rate monitoring methods: A reviewPediatric Pulmonology2011395
7Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisitionPediatric Pulmonology2001380
8Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosisPediatric Pulmonology2001361
9MucoidPseudomonas aeruginosa is a marker of poor survival in cystic fibrosisPediatric Pulmonology1992346
10The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosisPediatric Pulmonology1995320
11Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewPediatric Pulmonology2016297
12Glucocorticoids and lung development in the fetus and preterm infantPediatric Pulmonology2001262
13Polysomnographic values in children 2-9 years old: Additional data and review of the literaturePediatric Pulmonology2005261
14Pulmonary cysts in early childhood and the risk of malignancyPediatric Pulmonology2009257
15Vitamin D deficiency in young children with severe acute lower respiratory infectionPediatric Pulmonology2009256
16Global strategy for the diagnosis and management of asthma in children 5 years and youngerPediatric Pulmonology2011243
17Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasisPediatric Pulmonology2008239
18Prevalence of asthma-like symptoms in young childrenPediatric Pulmonology2007237
19Ventricular dysfunction in children with obstructive sleep apnea: Radionuclide assessmentPediatric Pulmonology1988233
20Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysisPediatric Pulmonology2017229
21Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosisPediatric Pulmonology2002228
22Body-mass index as a predictor of incident asthma in a prospective cohort of childrenPediatric Pulmonology2003228
23The global burden of respiratory disease-Impact on child healthPediatric Pulmonology2014221
24Pulmonary exacerbations in cystic fibrosisPediatric Pulmonology2004215
25Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysisPediatric Pulmonology1988214
26Clinical manifestations of children with COVID‐19: A systematic reviewPediatric Pulmonology2020213
27Sleep and breathing in Prader-Willi syndromePediatric Pulmonology2002211
28Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosisPediatric Pulmonology2011211
29Clinical characteristics of COVID‐19 in children: A systematic reviewPediatric Pulmonology2020207
30Spinal muscular atrophy type 1: Management and outcomesPediatric Pulmonology2002205
31Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn ScreeningPediatric Pulmonology2005205
32Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic FibrosisPediatric Pulmonology2001203
33Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasiaPediatric Pulmonology2005201
34Liquid ventilationPediatric Pulmonology1992200
35Anti‐inflammatory effects of macrolides in lung diseasePediatric Pulmonology2001194
36Association of apnea and nonacid gastroesophageal reflux in infants: Investigations with the intraluminal impedance techniquePediatric Pulmonology2001190
37Inflammation in cystic fibrosis: An updatePediatric Pulmonology2018187
38Spirometric reference values for white European children and adolescents: Polgar revisitedPediatric Pulmonology1995186
39Plastic bronchitis in children: A case series and review of the medical literaturePediatric Pulmonology2002185
40High‐flow nasal cannula: Impact on oxygenation and ventilation in an acute lung injury modelPediatric Pulmonology2011185
41Polysomnography in obese children with a history of sleep-associated breathing disordersPediatric Pulmonology1993182
42Pediatric asthma deaths in Victoria: The mild are at riskPediatric Pulmonology1992177
43The role of inflammation in the pathogenesis of bronchopulmonary dysplasiaPediatric Pulmonology1995177
44Foreign body aspiration: What is the outcome?Pediatric Pulmonology2002177
45Reduced neurocognition in children who snorePediatric Pulmonology2004173
46Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safetyPediatric Pulmonology2007173
47European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutationsPediatric Pulmonology2001172
48An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisPediatric Pulmonology2010169
49Detecting early structural lung damage in cystic fibrosisPediatric Pulmonology2002168
50Sleep-disordered breathing in 3,680 Greek childrenPediatric Pulmonology2004168